NuVasive
| Public (NASDAQ: NUVA) | |
| Industry | Medical Technology |
| Founded | 1997 |
| Headquarters | San Diego, California |
Key people | Alexis Lukianov (Chairman and CEO) |
| Products | Medical Devices |
| Revenue | $619 million (2012) |
| Website | http://www.nuvasive.com/ |
NuVasive, Inc., based in San Diego, California, is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders.[1] NuVasive is a publicly traded company and is listed on the NASDAQ under the symbol NUVA.
NuVasive’s product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products.
MAS combines three categories of NuVasive’s current product offerings: NeuroVision, a proprietary software-driven nerve avoidance system; MaXcess, a unique split-blade design retraction system; and specialized implants. The MAS platform enables procedures such as XLIF, or eXtreme Lateral Interbody Fusion, a minimally disruptive spine surgery that accesses the spine through the patient’s side. This procedure is a more modern surgical option for treatment of scoliosis than the Harrington Rod, which is no longer used.
References
External links
- NuVasive, Inc.
- http://www.lateralaccess.org
- http://www.xlif.com
- http://www.thebetterwayback.org/
- NuVasive at Yahoo! Finance
- NuVasive at The Motley Fool